Literature DB >> 7425039

Effects of topically applied occular decongestant and antihistamine.

M B Abelson, M R Allansmith, M H Friedlaender.   

Abstract

In two independent studies including 25 subjects each, naphazoline caused significant whitening (but did not prevent itching) in the histamine-induced red, itchy eye. Antazoline inhibited itching (but not redness) to a significant degree in the same model. The combination of naphazoline and antazoline produced significant whitening and inhibition of itching in all eyes challenged by histamine. The combination of the two drugs was more effective than either component alone in preventing redness. The antihistamine and combination of antihistamine/vasoconstrictor were equally effective in arresting itching.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7425039     DOI: 10.1016/s0002-9394(14)74864-0

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  5 in total

Review 1.  Therapeutic options in ocular allergic disease.

Authors:  M Hingorani; S Lightman
Journal:  Drugs       Date:  1995-08       Impact factor: 9.546

Review 2.  Drug treatment of allergic conjunctivitis. A review of the evidence.

Authors:  G Ciprandi; S Buscaglia; P M Cerqueti; G W Canonica
Journal:  Drugs       Date:  1992-02       Impact factor: 9.546

3.  Twice daily 4% Sodium Cromoglycate vs. 2% Sodium Cromoglycate used four times daily in seasonal (grass pollen) allergic conjunctivitis.

Authors:  L M Collum; S Fitzsimon; M Hillery; A Collum; W J Power; Z Pelikan; J B Jenson
Journal:  Doc Ophthalmol       Date:  1992       Impact factor: 2.379

Review 4.  Efficacy of levocabastine in conjunctival provocation studies.

Authors:  M Janssens
Journal:  Doc Ophthalmol       Date:  1992       Impact factor: 2.379

5.  The effect of ketotifen on inflammatory markers in allergic conjunctivitis: an open, uncontrolled study.

Authors:  Andrea P Martín; Julio Urrets-Zavalia; Alejandro Berra; Ana Lía Mariani; Norberto Gallino; Eduardo Gomez Demel; Julio Gagliardi; Carlos E Baena-Cagnani; Enrique Urrets-Zavalia; Horacio M Serra
Journal:  BMC Ophthalmol       Date:  2003-01-06       Impact factor: 2.209

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.